CINECA IRIS Institutional Research Information System

TAVERNA, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.910
EU - Europa 3.593
AS - Asia 1.898
AF - Africa 69
SA - Sud America 27
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.524
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.830
CN - Cina 1.321
IT - Italia 899
IE - Irlanda 487
SE - Svezia 437
DE - Germania 326
UA - Ucraina 309
FI - Finlandia 227
AT - Austria 221
FR - Francia 204
KR - Corea 193
GB - Regno Unito 129
VN - Vietnam 120
PL - Polonia 109
CA - Canada 71
BE - Belgio 67
IN - India 61
DK - Danimarca 60
SN - Senegal 56
HK - Hong Kong 36
TW - Taiwan 31
JP - Giappone 29
SG - Singapore 26
NL - Olanda 24
IR - Iran 23
AU - Australia 19
RU - Federazione Russa 19
BR - Brasile 18
CH - Svizzera 16
ES - Italia 15
IL - Israele 14
GR - Grecia 8
MY - Malesia 8
BY - Bielorussia 7
MX - Messico 7
RO - Romania 7
TR - Turchia 7
ID - Indonesia 6
TH - Thailandia 6
HR - Croazia 5
NZ - Nuova Zelanda 5
MU - Mauritius 4
PK - Pakistan 4
SI - Slovenia 4
ZA - Sudafrica 4
CO - Colombia 3
CZ - Repubblica Ceca 3
EU - Europa 3
NG - Nigeria 3
UZ - Uzbekistan 3
AR - Argentina 2
BG - Bulgaria 2
IQ - Iraq 2
QA - Qatar 2
SA - Arabia Saudita 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
EC - Ecuador 1
EG - Egitto 1
HU - Ungheria 1
IS - Islanda 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
SC - Seychelles 1
Totale 11.524
Salva come PNG Salva come JPEG
Città #
Chandler 849
Beijing 547
Dublin 484
Fairfield 462
Ann Arbor 388
Torino 275
Woodbridge 269
Ashburn 257
Houston 247
Vienna 220
Wilmington 208
Dearborn 189
Seattle 175
Jacksonville 158
Nyköping 151
Cambridge 142
Medford 141
Princeton 139
Hangzhou 127
Villeurbanne 126
Pisa 111
Fremont 102
Warsaw 98
Turin 83
Milan 77
Shanghai 77
Dong Ket 71
Guangzhou 71
Nanjing 71
Boardman 56
Boston 53
Brussels 45
Redwood City 42
New York 33
Menlo Park 31
San Diego 31
Xian 27
Jinan 24
Kunming 24
Chengdu 22
Düsseldorf 22
Hefei 22
Norwalk 22
Zhengzhou 22
Phoenix 21
Taipei 21
Toronto 21
Wuhan 20
Falls Church 19
Chongqing 18
Verona 17
Changsha 16
Munich 16
Silver Spring 16
Fuzhou 15
Gießen 14
Nanchang 13
Ottawa 13
Tokyo 13
Washington 12
Gent 11
Central District 10
Hong Kong 10
Lachine 10
Pune 10
Seoul 10
Los Angeles 9
Moscow 9
Novara 9
Santhià 9
Singapore 9
Hebei 8
Amsterdam 7
Dallas 7
Helsinki 7
Saluzzo 7
San Lazzaro Di Savena 7
Shenyang 7
São Paulo 7
Tianjin 7
Harbin 6
London 6
Montreal 6
Mountain View 6
Upper Marlboro 6
Aquila 5
Barcelona 5
Berlin 5
Buffalo 5
Chennai 5
Des Moines 5
Edinburgh 5
Guiyang 5
Heidelberg 5
Pittsburgh 5
San Mateo 5
Trieste 5
Avezzano 4
Birmingham 4
Central 4
Totale 7.328
Salva come PNG Salva come JPEG
Nome #
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS and CSF1 639
Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy 277
microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. 250
Mir-214 and mir-148b targeting inhibits dissemination of melanoma and breast cancer 245
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy. 236
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 214
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 203
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 202
miR-214 as a Key Hub that Controls Cancer Networks: Small Player, Multiple Functions 197
miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation. 193
microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis 193
Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells 186
MiR-146a exerts differential effects on melanoma growth and metastatization 184
Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion 180
CyTRANSFINDER: A Cytoscape 3.3 plugin for three-component (TF, gene, miRNA) signal transduction pathway construction 176
Acquired resistance to clinical cancer therapy: A twist in physiological signaling 170
Expression of AP-2a, AP-2g and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value 168
miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions 165
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells 147
The p140Cap adaptor protein as a molecular hub to block cancer aggressiveness 140
Stem Cell-Derived, microRNA-Carrying Extracellular Vesicles: A Novel Approach to Interfering with Mesangial Cell Collagen Production in a Hyperglycaemic Setting. 139
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells 138
Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma 135
AGO2 promotes telomerase activity and interaction between the telomerase components TERT and TERC 128
Novel role of microRNA146b in promoting mammary alveolar progenitor cell maintenance 125
IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway 125
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3 125
CircuitsDB: a database of mixed microRNA/transcription factor feed-forward regulatory circuits in human and mouse 124
Interfering with inflammation: a new strategy to block breast cancer self-renewal and progression? 122
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2 117
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 112
How do Treg cell function and related cytokines levels change in alemtuzumab treated patients? A 24 months immunological study 111
Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes 108
microRNA-214 promotes melanoma tumor progression 105
Modulation of miR-214 in tumor cells 104
The formation of STAT5/PPARG transcriptional complex modulates angiogenic cell bioavailability in diabetes 103
The AP-2alpha and AP-2gamma transcription factors regulate tumor formation 96
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs 94
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 93
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 88
3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner 87
Endothelial and Smooth muscle cell Derived Neuropin-like molecule and AP-2 family protein expression in primary melanoma predicts Disease Free Survival in melanoma patients 87
The AP-2alpha transcription factor regulates tumor cell migration and apoptosis 85
Formation of STAT5/PPAR{gamma} Transcriptional Complex Modulates Angiogenic Cell Bioavailability in Diabetes 85
The AP-2alpha and AP-2gamma transcription factors regulate tumor formation and progression via specific genetic programs 85
Treg Cell Function and Related Cytokines and Chemokines Changes during Alemtuzumab Treatment: a 24 Months Immunological Study 82
Alemtuzumab treatment in MS how do the Treg cell function and suppressor cytokine mRNA (IL-10, TGF-beta, IL_27) levels change? 24-month immunological report during 323 and 324 genzyme trials 81
Characterization of the cellular functions of KRIT1, the disease gene responsible for type 1 Cerebral Cavernous Malformations (CCM1) 80
miR-148b is a major coordinator in a Relapse-associated miR signature in Breast Tumors. 80
AP-2alpha regulates migration of GN-11 neurons via a specific genetic programme involving the Axl receptor tyrosine kinase 79
Investigating the epi-miRNome: Identification of epi-miRNAs using transfection experiments 79
Do predicted microRNAs control gene networks involved in breast cancer progression? 78
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 77
microRNA and cancer progression in Breast Tumours 75
T Regulatories (Tregs) and suppressor cytokine mRNA (IL-10, TGF-beta, IL-27) increase after Alemtuzumab in MS: First 25 Month Immunological Report on 323 and 324 Genzyme trials 75
Alemtuzumab long-lasting immunological effects: a 48 months follow-up observation 74
Identification of new genes associated with breast cancer progression by gene expression analysis of pre-defined sets of neoplastic tissues 73
The role of melatonin on miRNAs modulation in triple-negative breast cancer cells 73
MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment 73
A direct test of potential roles for b3 and b5 integrins in growth and metastasis of murine mammary carcinomas. 71
Co-occurrence of substance P and enkephalin-like immunoreactivities in the prosencephalon of two amphibians. 71
Co-localization of AP2alpha transcription factor and TH-immunoreactive neurons in mouse locus coeruleus 71
Oestrogen and epidermal growth factor down-regulate erbB-2 oncogene protein expression in breast cancer cells by different mechanisms. 69
Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. 69
Analysis of the regulatory regions of AP-2alpha-modulated genes selected for oral presentation and winner of the "Premio Chiara D'Onofrio Giovani Riercatori 2009" 69
THE AP-2ALPHA TRANSCRIPTION FACTOR REGULATES TUMOUR CELL MIGRATION 69
In vivo roles of integrins during leukocyte development and traffic: insights from the analysis of mice chimeric for alpha 5, alpha v, and alpha 4 integrins. 67
Growth suppression of normal mammary epithelial cells by wild-type p53. 67
microRNAs and cancer progression in Breast Tumours 66
erbB-2 expression in estrogen-receptor-positive breast-tumor cells is regulated by growth-modulatory reagents. 65
ACTIVATOR PROTEIN-2 ALPHA TRANSCRIPTION FACTOR ROLES IN NEURONS 65
Do predicted microRNAs control gene networks involved in breast cancer progression? 65
microRNA and cancer progression in Breast Tumours 64
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models 64
The Ap-Alpha transcription factor regulates tumor cell migration 62
miR-21 coordinates tumor growth and modulates KRIT1 levels 61
microRNAs in breast tumors 60
A test of the role of alpha5 integrin/fibronectin interactions in tumorigenesis. 59
New genes associated with breast cancer progression identified by gene expression analysis 59
microRNA and cancer progression in Breast Tumours 59
Role of miRNAs in tumor and endothelial cell interactions during tumor progression 59
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 58
The AP-2alpha and AP-2gamma transcription factors regulate tumor formation and progression via specific genetic programsselected for oral presentation 57
Surface expression of erbB-2 protein is post-transcriptionally regulated in mammary epithelial cells by epidermal growth factor and by the culture density. 56
The diverse roles of integrins and their ligands in angiogenesis. 56
Application of microcomputer-aided image analysis and immunocytochemical (ICC) methods to studies on the colocalization of neuroactive substances in the central nervous system (CNS). 56
The AP-2alpha and AP-2gamma transcription factors regulate tumor progression and cell movement via specific genetic programs 56
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression 56
Do predicted microRNAs control gene networks involved in breast cancer progression? 55
Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up 54
The int-2 gene product acts as a growth factor and substitutes for basic fibroblast growth factor in promoting the differentiation of a normal mouse mammary epithelial cell line. 53
miR214 expression and interconnected endothelial and smooth muscle cell derived neutropilin-like molecule ESDN and AP-2 family protein expression in primary melanoma 53
Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. 53
NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells. 52
microRNAs in breast tumors 52
The v-raf and Ha-ras oncogenes inhibit transcription from the beta-casein gene promoter by interfering with a mammary gland specific transcription factor 50
DIFFERENTIAL REGULATION OF AP-2 TRANSCRIPTION FACTOR GENE EXPRESSION BY ESTROGEN IN HUMAN BREAST CANCER CELLS 49
microRNA and cancer progression in Breast Tumours 49
Growth suppression of normal mammary epithelial cells by wild-type p53. 49
The effect of extracellular matrix upon HC11 mammary epithelial cell differentiation. 48
Totale 10.608
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.147
article - articoli 0
book - libri 0
conference - conferenze 8.178
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.325
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019614 0 0 0 0 0 0 0 0 0 160 318 136
2019/20201.917 106 90 130 222 167 291 239 143 184 164 115 66
2020/20211.451 137 92 93 93 177 91 130 69 161 126 84 198
2021/20221.545 76 61 84 123 64 65 75 83 42 147 386 339
2022/20232.440 240 183 44 289 235 553 153 160 324 60 137 62
2023/2024723 135 155 48 70 74 97 31 52 18 43 0 0
Totale 11.873